Andrew Schwendenman - 10 Aug 2026 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Reporting relationship: Chief Accounting Officer
Issuer ticker: REPL
Reported as of: 10 Aug 2026
Net transaction value: -$98,987
SEC form: 4
Accepted by SEC: 12 Aug 2026, 17:04:06 UTC
Prior SEC filing: 20 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Shawn Glidden, attorney-in-fact

Key filing fact

Andrew Schwendenman filed Form 4 for Replimune Group, Inc. (REPL) on 12 Aug 2026.

Key facts

This page summarizes Andrew Schwendenman's Form 4 filing for Replimune Group, Inc. (REPL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Aug 2026, 17:04.

Change

Previous filing in this sequence was filed on 20 May 2026.
Current net transaction value: -$98,987.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001977879 Primary reporting owner

Schwendenman Andrew

Relationship: Chief Accounting Officer
Address: C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK DRIVE, SUITE 303, WOBURN
Signature: /s/ Shawn Glidden, attorney-in-fact
Signature date: 12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REPL transaction

Common Stock

Sale

Transaction value: $98,987
Shares: -7,632
Change %: -7.1%
Price: $12.97
Shares after: 99,425
Date: 10 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the vesting of the Reporting Person's performance-based restricted stock units (the "PSUs"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the PSUs were granted and does not represent a discretionary sale by the Reporting Person.